A randomised study of oral versus intravenous chemotherapy in poor prognosis small cell lung cancer (SCLC)
Completed
- Conditions
- ung (small cell)CancerLung (small cell)
- Registration Number
- ISRCTN73797340
- Lead Sponsor
- K Co-ordinating Committee for Cancer Research (UKCCCR)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Histologically or cytologically proven SCLC
2. Patients with extensive disease and poor prognosis, i.e., Eastern Cooperative Oncology Group (ECOG) performance 2 or 3 or alkaline phosphatase >1.5 upper limit normal range
3. Patients 75 years and over, whatever stage of disease, deemed fit for randomisation
4. No previous malignancy, except non-melanomatous skin cancer in the preceding 3 years
5. No medical contraindications to treatment
6. Adequate renal function
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration
- Secondary Outcome Measures
Name Time Method ot provided at time of registration